Resolution of extravascular hemolysis with oral iptacopan monotherapy in a patient with treatment experienced paroxysmal nocturnal hemoglobinuria (PNH)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Resolution of extravascular hemolysis with oral iptacopan monotherapy in a patient with treatment experienced paroxysmal nocturnal hemoglobinuria (PNH) ; volume:136 ; number:15-16 ; day:1 ; month:7 ; year:2024 ; pages:472-475 ; date:8.2024
Wiener klinische Wochenschrift ; 136, Heft 15-16 (1.7.2024), 472-475, 8.2024
- Creator
-
Füreder, Wolfgang
Thalhammer, Renate
Valent, Peter
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00508-024-02390-w
- URN
-
urn:nbn:de:101:1-2411022119264.906186792745
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Füreder, Wolfgang
- Thalhammer, Renate
- Valent, Peter
- SpringerLink (Online service)
Other Objects (12)
Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy– a report of two cases
Paroxysmal nocturnal hemoglobinuria: Where we stand
The complement model disease paroxysmal nocturnal hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment
Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events
The Antibody Repertoire of Patients with Paroxysmal Nocturnal Hemoglobinuria and Myelodysplastic Syndrome
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors
Normalization of Hemoglobin, Lactate Dehydrogenase, and Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan
Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH)
Correction to: Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria
Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy– a report of two cases
Paroxysmal nocturnal hemoglobinuria: Where we stand
The complement model disease paroxysmal nocturnal hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment
Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events
The Antibody Repertoire of Patients with Paroxysmal Nocturnal Hemoglobinuria and Myelodysplastic Syndrome
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors
Normalization of Hemoglobin, Lactate Dehydrogenase, and Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan
Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH)
Correction to: Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria
Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy– a report of two cases
Paroxysmal nocturnal hemoglobinuria: Where we stand
The complement model disease paroxysmal nocturnal hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment
Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events
The Antibody Repertoire of Patients with Paroxysmal Nocturnal Hemoglobinuria and Myelodysplastic Syndrome
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors
Normalization of Hemoglobin, Lactate Dehydrogenase, and Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan
Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH)